Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by W Wiersinga and Alexander Vlaar.
W Wiersinga
Connection Strength
0.463
Alexander Vlaar
  1. Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec; 2(12):e764-e773.
    View in: PubMed
    Score: 0.226
  2. Transfusion of 35-day-stored red blood cells does not alter lipopolysaccharide tolerance during human endotoxemia. Transfusion. 2017 06; 57(6):1359-1368.
    View in: PubMed
    Score: 0.178
  3. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine. 2021 May; 67:103378.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.